Home > Boards > Canadian > Medical - Psychedelics > Pure Extracts Technologies Corp. (PRXTF)

December 30, 2020 PR, Pure Extracts Commences Study

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
barnyarddog Member Profile
 
Followed By 12
Posts 1,603
Boards Moderated 0
Alias Born 08/05/19
160x600 placeholder
barnyarddog   Friday, 01/08/21 05:27:21 AM
Re: None
Post # of 6 
December 30, 2020 PR, Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it is commencing a study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at the Toronto Institute of Pharmaceutical Technology (“TIPT”) by Dr. Alexander MacGregor, a key scientific advisor to the Company.

... His company has a Health Canada Drug Establishment License, a Cannabis Drug License and a Dealer’s License issued under the Controlled Drugs and Substances Act (CDSA) and is thus licensed to possess psychedelic drug compounds.

https://pureextractscorp.com/news/pure-extracts-commences-study-on-psilocybin-oral-tablets-capsules-and-nasal-gel

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences